A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible.
from NYT > Well https://ift.tt/2ReyIXD
Ad Unit (Iklan) BIG
For promotion or buying this site, please contact xl4bhi@gmail.com
Post a Comment
Post a Comment